Indeed, serum concentrations of MMP2, MMP9, TIMP1, TIMP2, MMP7, TGF-β1 and -β2 were found to be significantly higher in NAFLD patients compared to controls, yet these markers are unable to distinguish between steatosis and steatohepatitis. This evidence concerns the gene TIMP2 and metabolic dysfunction-associated steatotic liver disease.